FLUOCINOLONE ACETONIDE

FLUOCINOLONE ACETONIDE was reported 3766 times

FLUOCINOLONE ACETONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CILIARY BODY OPERATION 11 1.0000
1 SCLEROTOMY 5 0.8333
2 SCLERAL OPERATION 4 0.5714
3 INTERNAL LIMITING MEMBRANE PEELING 7 0.5385
4 TRABECULOPLASTY 20 0.5128
5 POTASSIUM HYDROXIDE PREPARATION POSITIVE 3 0.5000
6 GLAUCOMA DRAINAGE DEVICE PLACEMENT 18 0.3103
7 TRABECULECTOMY 24 0.2609
8 RETINAL LASER COAGULATION 5 0.1852
9 DRUG IMPLANTATION 2 0.1818
10 ANORECTAL INFECTION BACTERIAL 2 0.1333
11 SKIN TEMPERATURE 3 0.1304
12 IMPLANTATION COMPLICATION 26 0.1250
13 OPHTHALMIC FLUID DRAINAGE 3 0.1034
14 CORNEAL DECOMPENSATION 16 0.0994
15 VITRECTOMY 58 0.0973
16 MEDICAL DEVICE REPOSITIONING 3 0.0938
17 HYPOTONY OF EYE 39 0.0929
18 MEDICAL DEVICE REMOVAL 108 0.0624
19 LENS EXTRACTION 2 0.0526
20 OCULAR LYMPHOMA 7 0.0496
21 MACULAR THICKENING 4 0.0476
22 OPTIC NERVE CUPPING 6 0.0472
23 BLOOD SMEAR TEST ABNORMAL 3 0.0375
24 GLAUCOMA SURGERY 9 0.0352
25 EPINEPHRINE INCREASED 3 0.0333
26 CHORIORETINAL FOLDS 2 0.0282
27 RETINITIS VIRAL 3 0.0248
28 IRIS NEOVASCULARISATION 3 0.0240
29 DIABETIC RETINAL OEDEMA 12 0.0236
30 PATIENT UNCOOPERATIVE 11 0.0232
31 INTRAOCULAR LENS IMPLANT 11 0.0222
32 DRUG DELIVERY SYSTEM ISSUE 43 0.0218
33 CORNEAL OEDEMA 48 0.0214
34 RHEGMATOGENOUS RETINAL DETACHMENT 4 0.0191
35 LENS DISLOCATION 4 0.0190
36 OPTIC DISC DISORDER 4 0.0190
37 INVESTIGATION NONCOMPLIANCE 2 0.0183
38 RETINAL CYST 3 0.0181
39 DEVICE DISPENSING ERROR 19 0.0161
40 CHOROIDAL HAEMORRHAGE 3 0.0155
41 INTRAOCULAR PRESSURE INCREASED 198 0.0155
42 CHOROIDAL DETACHMENT 8 0.0144
43 EPIRETINAL MEMBRANE 4 0.0144
44 RETINAL OPERATION 4 0.0143
45 NECROTISING RETINITIS 9 0.0141
46 OCULAR HYPERTENSION 27 0.0139
47 ERYTHEMA ANNULARE 4 0.0138
48 RETINAL OCCLUSIVE VASCULITIS 3 0.0134
49 ANTERIOR CHAMBER FLARE 3 0.0129
50 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 3 0.0129
51 VITREOUS HAEMORRHAGE 34 0.0123
52 EYE HAEMATOMA 3 0.0114
53 EYE COMPLICATION ASSOCIATED WITH DEVICE 3 0.0112
54 STEROID WITHDRAWAL SYNDROME 11 0.0108
55 SUDDEN VISUAL LOSS 3 0.0108
56 TOPICAL STEROID WITHDRAWAL REACTION 4 0.0103
57 DEAFNESS PERMANENT 2 0.0102
58 EYE LASER SURGERY 6 0.0102
59 DEVICE FAILURE 151 0.0099
60 BIRTH MARK 2 0.0096
61 INJURY CORNEAL 5 0.0096
62 INTRAOCULAR PRESSURE DECREASED 5 0.0095
63 LASER THERAPY 2 0.0089
64 MACULAR FIBROSIS 6 0.0088
65 INTRA-OCULAR INJECTION COMPLICATION 2 0.0088
66 POSTERIOR CAPSULE OPACIFICATION 3 0.0087
67 EUSTACHIAN TUBE DYSFUNCTION 5 0.0087
68 CYSTOID MACULAR OEDEMA 16 0.0085
69 CREST SYNDROME 2 0.0084
70 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 3 0.0084
71 RETINAL DEGENERATION 10 0.0077
72 CYTOMEGALOVIRUS CHORIORETINITIS 15 0.0077
73 CHOROIDAL EFFUSION 6 0.0075
74 BODY TINEA 4 0.0071
75 HEPATITIS B SURFACE ANTIBODY POSITIVE 2 0.0068
76 CATARACT OPERATION 40 0.0067
77 LENTIGO 3 0.0060
78 IRIS ADHESIONS 3 0.0058
79 HYPHAEMA 3 0.0057
80 XEROSIS 7 0.0057
81 KERATOCONUS 2 0.0053
82 HERPES OPHTHALMIC 7 0.0053
83 HERPES SIMPLEX REACTIVATION 2 0.0052
84 SUTURE INSERTION 3 0.0051
85 DRUG DELIVERY SYSTEM MALFUNCTION 26 0.0051
86 ADRENAL ADENOMA 3 0.0050
87 ENDOPHTHALMITIS 30 0.0050
88 MACULAR OEDEMA 28 0.0050
89 SEBORRHOEIC KERATOSIS 7 0.0048
90 EYE OPERATION 22 0.0048
91 GLIOSIS 2 0.0047
92 HAEMANGIOMA OF SKIN 2 0.0046
93 KERATOACANTHOMA 3 0.0044
94 BILIARY SEPSIS 2 0.0043
95 ECZEMA HERPETICUM 2 0.0043
96 VITRITIS 8 0.0043
97 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 141 0.0042
98 OTITIS EXTERNA 5 0.0041
99 STAPHYLOCOCCAL SKIN INFECTION 5 0.0041
100 MICROALBUMINURIA 3 0.0040
101 GLARE 2 0.0039
102 CONJUNCTIVAL OEDEMA 4 0.0039
103 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
104 SKIN WEEPING 13 0.0036
105 SEBORRHOEIC DERMATITIS 6 0.0036
106 VITREOUS OPACITIES 3 0.0036
107 HEPATITIS A 3 0.0035
108 NON-INFECTIOUS ENDOPHTHALMITIS 3 0.0035
109 LIFE EXPECTANCY SHORTENED 2 0.0035
110 DEVICE DISLOCATION 149 0.0034
111 PRODUCT ADMINISTRATION ERROR 69 0.0034
112 ANTERIOR CHAMBER INFLAMMATION 2 0.0034
113 NEEDLE ISSUE 97 0.0033
114 CERUMEN IMPACTION 3 0.0033
115 CORNEAL DISORDER 7 0.0032
116 MEDICAL DEVICE IMPLANTATION 5 0.0032
117 EYELID RASH 3 0.0031
118 CATARACT NUCLEAR 2 0.0030
119 GLAUCOMA 57 0.0030
120 CYST RUPTURE 2 0.0029
121 ANTERIOR CHAMBER CELL 2 0.0028
122 GENITAL PAIN 4 0.0027
123 HALO VISION 3 0.0027
124 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
125 CORNEAL TRANSPLANT 2 0.0026
126 CUSHINGOID 8 0.0025
127 SKIN EROSION 8 0.0025
128 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
129 GUTTATE PSORIASIS 2 0.0024
130 RETINAL TEAR 6 0.0024
131 HAND-FOOT-AND-MOUTH DISEASE 2 0.0024
132 VITREOUS FLOATERS 23 0.0023
133 ENDOCRINE OPHTHALMOPATHY 2 0.0023
134 CYSTOCELE 2 0.0023
135 PAPULE 16 0.0023
136 SKIN PLAQUE 19 0.0023
137 BLOOD ALBUMIN INCREASED 2 0.0022
138 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 38 0.0022
139 CORNEAL OPACITY 3 0.0022
140 CORNEAL ABRASION 3 0.0022
141 RETINAL DETACHMENT 20 0.0022
142 MACULE 6 0.0022
143 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
144 VARICELLA 5 0.0021
145 FOREIGN BODY IN EYE 2 0.0021
146 MENTAL FATIGUE 3 0.0020
147 EPICONDYLITIS 3 0.0020
148 EYELID PAIN 4 0.0020
149 ANAL PRURITUS 4 0.0019
150 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
151 EAR SWELLING 4 0.0019
152 ENTEROCOCCAL BACTERAEMIA 2 0.0019
153 SCLERITIS 3 0.0019
154 SKIN DISCOMFORT 5 0.0019
155 EPSTEIN-BARR VIRAEMIA 2 0.0018
156 SCRATCH 19 0.0018
157 RHINITIS ALLERGIC 8 0.0018
158 TEMPERATURE REGULATION DISORDER 4 0.0018
159 DERMATITIS ATOPIC 94 0.0018
160 SKIN HYPERTROPHY 5 0.0018
161 ADMINISTRATION SITE PAIN 2 0.0017
162 VITILIGO 4 0.0017
163 LYMPHOPROLIFERATIVE DISORDER 5 0.0017
164 PRURITUS GENITAL 4 0.0017
165 INGROWING NAIL 4 0.0017
166 EYE INFLAMMATION 16 0.0017
167 EYELID SKIN DRYNESS 2 0.0016
168 ESSENTIAL HYPERTENSION 3 0.0016
169 DRUG DOSE TITRATION NOT PERFORMED 3 0.0016
170 COMPLICATION OF DEVICE INSERTION 32 0.0016
171 MELANOCYTIC NAEVUS 7 0.0016
172 SNORING 6 0.0016
173 LIP HAEMORRHAGE 2 0.0016
174 HEPATOSPLENOMEGALY 4 0.0016
175 HERPES SIMPLEX 10 0.0015
176 ACROCHORDON 2 0.0015
177 LIP EXFOLIATION 2 0.0015
178 MENISCUS INJURY 9 0.0015
179 JOINT INSTABILITY 2 0.0014
180 OPTIC NEUROPATHY 3 0.0014
181 LYMPHOCYTOSIS 3 0.0014
182 INFUSION SITE BRUISING 3 0.0014
183 VITREOUS DETACHMENT 3 0.0014
184 EXCESSIVE EYE BLINKING 2 0.0014
185 CONJUNCTIVITIS ALLERGIC 2 0.0013
186 NEURODERMATITIS 5 0.0013
187 ASTIGMATISM 2 0.0013
188 KERATITIS 4 0.0013
189 LICHEN PLANUS 3 0.0013
190 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
191 EYELIDS PRURITUS 4 0.0013
192 KERATOPATHY 2 0.0013
193 VISUAL FIELD DEFECT 9 0.0012
194 AORTIC VALVE DISEASE 2 0.0012
195 COLON CANCER METASTATIC 2 0.0012
196 NEUROLOGICAL SYMPTOM 7 0.0012
197 TRIGGER FINGER 5 0.0012
198 SKIN ATROPHY 7 0.0012
199 CATHETER SITE HAEMORRHAGE 3 0.0012
200 EYELID IRRITATION 3 0.0012
201 B-CELL LYMPHOMA 4 0.0012
202 DEAFNESS BILATERAL 2 0.0012
203 ANGLE CLOSURE GLAUCOMA 3 0.0012
204 GAZE PALSY 2 0.0012
205 ACUTE SINUSITIS 2 0.0012
206 DERMATITIS 24 0.0011
207 TYPE I HYPERSENSITIVITY 4 0.0011
208 BREAST CYST 2 0.0011
209 ECZEMA 59 0.0011
210 SEBORRHOEA 4 0.0011
211 DEAFNESS UNILATERAL 6 0.0011
212 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
213 SKIN HAEMORRHAGE 16 0.0011
214 ELECTRIC SHOCK SENSATION 3 0.0011
215 SCAB 12 0.0011
216 RETINAL VEIN OCCLUSION 3 0.0010
217 SKIN SWELLING 9 0.0010
218 VISUAL ACUITY REDUCED 34 0.0010
219 SKIN FISSURES 20 0.0010
220 PSORIASIS 133 0.0010
221 BLINDNESS 41 0.0010
222 SKIN PAPILLOMA 4 0.0010
223 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
224 EAR HAEMORRHAGE 2 0.0010
225 EYE INJURY 3 0.0010
226 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
227 PIGMENTATION DISORDER 6 0.0010
228 SCOLIOSIS 6 0.0010
229 IRIDOCYCLITIS 3 0.0009
230 SKIN EXFOLIATION 80 0.0009
231 EYE CONTUSION 2 0.0009
232 PROCTALGIA 6 0.0009
233 BLOOD TESTOSTERONE INCREASED 2 0.0009
234 CHAPPED LIPS 4 0.0009
235 HENOCH-SCHONLEIN PURPURA 2 0.0009
236 INFUSION SITE HAEMORRHAGE 3 0.0009
237 SPINAL OSTEOARTHRITIS 8 0.0009
238 ASTHENOPIA 5 0.0009
239 COLONOSCOPY 2 0.0009
240 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
241 EAR DISCOMFORT 9 0.0009
242 REGURGITATION 3 0.0009
243 CONJUNCTIVITIS 16 0.0009
244 ERYTHEMA MULTIFORME 8 0.0009
245 DISCOMFORT 52 0.0009
246 ESCHERICHIA BACTERAEMIA 2 0.0008
247 SEASONAL ALLERGY 12 0.0008
248 SPINAL COLUMN STENOSIS 4 0.0008
249 MACULOPATHY 3 0.0008
250 CONJUNCTIVAL HYPERAEMIA 3 0.0008
251 MONOCYTE COUNT INCREASED 3 0.0008
252 DERMAL CYST 2 0.0008
253 EYE INFECTION 9 0.0008
254 SWELLING OF EYELID 5 0.0008
255 INFUSION SITE SWELLING 5 0.0008
256 KLEBSIELLA INFECTION 4 0.0008
257 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
258 THYROID MASS 3 0.0008
259 FOOD ALLERGY 6 0.0008
260 ACTINIC KERATOSIS 2 0.0008
261 WOUND SECRETION 3 0.0008
262 EYE PAIN 43 0.0008
263 SKIN DISCOLOURATION 35 0.0008
264 HYPERPHAGIA 3 0.0008
265 SKIN MASS 5 0.0007
266 BLEPHARITIS 3 0.0007
267 ALCOHOL ABUSE 2 0.0007
268 EYE PRURITUS 25 0.0007
269 BLOOD SODIUM INCREASED 2 0.0007
270 CHEILITIS 4 0.0007
271 ERYTHEMA OF EYELID 4 0.0007
272 UVEITIS 10 0.0007
273 SLEEP DISORDER 52 0.0007
274 APPLICATION SITE HAEMORRHAGE 2 0.0007
275 NO ADVERSE EVENT 132 0.0007
276 ONYCHOCLASIS 5 0.0007
277 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
278 EAR PAIN 14 0.0007
279 VITAMIN D DEFICIENCY 7 0.0007
280 PRODUCT DOSE OMISSION ISSUE 210 0.0007
281 SKIN REACTION 10 0.0007
282 CATARACT 42 0.0007
283 RETINAL HAEMORRHAGE 5 0.0007
284 LIP PAIN 2 0.0007
285 FIBULA FRACTURE 2 0.0007
286 MUSCLE STRAIN 6 0.0007
287 OFF LABEL USE 606 0.0007
288 SKIN DISORDER 23 0.0007
289 WHEELCHAIR USER 3 0.0007
290 EYE HAEMORRHAGE 9 0.0007
291 EAR DISORDER 3 0.0007
292 APHTHOUS ULCER 5 0.0006
293 ROSACEA 3 0.0006
294 EAR INFECTION 17 0.0006
295 SECRETION DISCHARGE 8 0.0006
296 BLOOD CREATININE DECREASED 2 0.0006
297 PHOTOPHOBIA 12 0.0006
298 MULTIPLE ALLERGIES 5 0.0006
299 DERMATITIS ALLERGIC 8 0.0006
300 APPLICATION SITE PAIN 14 0.0006
301 INFUSION SITE PRURITUS 2 0.0006
302 FURUNCLE 5 0.0006
303 VISUAL IMPAIRMENT 78 0.0006
304 IMPAIRED QUALITY OF LIFE 9 0.0006
305 DRY SKIN 83 0.0006
306 RHINITIS 5 0.0006
307 DERMATITIS CONTACT 7 0.0006
308 LYMPHOCYTE COUNT INCREASED 2 0.0006
309 PROTEIN URINE PRESENT 3 0.0006
310 PRURITUS 231 0.0006
311 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
312 POST-TRAUMATIC STRESS DISORDER 4 0.0006
313 DYSLIPIDAEMIA 3 0.0006
314 APPLICATION SITE DRYNESS 2 0.0006
315 HEPATIC CYST 2 0.0006
316 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
317 TRISMUS 3 0.0006
318 THERAPY NON-RESPONDER 26 0.0006
319 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
320 RASH MACULAR 20 0.0006
321 EAR PRURITUS 2 0.0006
322 SENSITIVITY TO WEATHER CHANGE 3 0.0006
323 HAND FRACTURE 4 0.0006
324 DEVICE PLACEMENT ISSUE 2 0.0006
325 INJECTION SITE DISCHARGE 3 0.0006
326 SKIN CANCER 12 0.0006
327 ANAL ABSCESS 3 0.0006
328 SINUS DISORDER 11 0.0006
329 FAECALOMA 3 0.0005
330 PHOTOSENSITIVITY REACTION 9 0.0005
331 SENSITIVE SKIN 4 0.0005
332 HIATUS HERNIA 7 0.0005
333 CANDIDA INFECTION 9 0.0005
334 CHRONIC SINUSITIS 2 0.0005
335 PULMONARY CONGESTION 7 0.0005
336 PERONEAL NERVE PALSY 3 0.0005
337 SLEEP APNOEA SYNDROME 10 0.0005
338 HYPERTONIA 3 0.0005
339 PAIN OF SKIN 14 0.0005
340 DEVICE USE ISSUE 9 0.0005
341 ORAL HERPES 10 0.0005
342 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
343 DECREASED INTEREST 3 0.0005
344 OCULAR HYPERAEMIA 24 0.0005
345 BLADDER DISORDER 5 0.0005
346 HYPERLIPIDAEMIA 6 0.0005
347 CEREBRAL ATROPHY 2 0.0005
348 HYPOTONIA 5 0.0005
349 DRY EYE 25 0.0005
350 DEVICE DIFFICULT TO USE 33 0.0005
351 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
352 FUNGAL SKIN INFECTION 2 0.0005
353 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
354 DERMATITIS ACNEIFORM 3 0.0005
355 APPLICATION SITE PRURITUS 11 0.0005
356 INJECTION SITE DISCOLOURATION 6 0.0005
357 NASAL DRYNESS 3 0.0005
358 THERAPEUTIC RESPONSE DECREASED 29 0.0005
359 BLEPHAROSPASM 3 0.0005
360 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
361 SENSATION OF FOREIGN BODY 4 0.0005
362 PHOTOPSIA 3 0.0005
363 DRUG DOSE OMISSION BY DEVICE 37 0.0005
364 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
365 AORTIC VALVE INCOMPETENCE 2 0.0005
366 INTERVERTEBRAL DISC DISORDER 2 0.0005
367 SKIN HYPERPIGMENTATION 4 0.0005
368 PHARYNGITIS STREPTOCOCCAL 5 0.0005
369 SKIN LACERATION 5 0.0005
370 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
371 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
372 URINE OUTPUT DECREASED 4 0.0005
373 DIVERTICULUM INTESTINAL 2 0.0005
374 PRODUCT PREPARATION ISSUE 3 0.0005
375 NAIL DISORDER 4 0.0005
376 TOOTH INFECTION 6 0.0005
377 WALKING AID USER 3 0.0005
378 SARS-COV-2 TEST POSITIVE 6 0.0005
379 IRON DEFICIENCY 2 0.0004
380 COLITIS ISCHAEMIC 3 0.0004
381 MITRAL VALVE INCOMPETENCE 5 0.0004
382 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
383 HAEMOGLOBIN INCREASED 2 0.0004
384 MICTURITION URGENCY 5 0.0004
385 SKIN LESION 12 0.0004
386 SKIN IRRITATION 20 0.0004
387 FORMICATION 3 0.0004
388 LACRIMATION INCREASED 13 0.0004
389 CARPAL TUNNEL SYNDROME 6 0.0004
390 PRODUCT QUALITY ISSUE 58 0.0004
391 FLANK PAIN 4 0.0004
392 ARTERIOSCLEROSIS 4 0.0004
393 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
394 FEAR OF INJECTION 3 0.0004
395 PSORIATIC ARTHROPATHY 17 0.0004
396 INCREASED APPETITE 8 0.0004
397 RASH ERYTHEMATOUS 20 0.0004
398 HEPATITIS C 5 0.0004
399 BURSITIS 5 0.0004
400 NEURALGIA 10 0.0004
401 HAEMORRHOIDS 8 0.0004
402 PHARYNGEAL SWELLING 4 0.0004
403 BLINDNESS TRANSIENT 3 0.0004
404 RASH 177 0.0004
405 ARTHROPOD BITE 3 0.0004
406 FOOT OPERATION 2 0.0004
407 CYST 5 0.0004
408 SUNBURN 3 0.0004
409 INJECTION SITE INFLAMMATION 2 0.0004
410 SYRINGE ISSUE 7 0.0004
411 DERMATITIS EXFOLIATIVE 2 0.0004
412 EYE IRRITATION 23 0.0004
413 BREAST TENDERNESS 3 0.0004
414 EYE DISORDER 13 0.0004
415 OSTEOPENIA 6 0.0004
416 AORTIC ANEURYSM 3 0.0004
417 DRY THROAT 4 0.0004
418 BOWEL MOVEMENT IRREGULARITY 3 0.0004
419 PROCEDURAL COMPLICATION 3 0.0004
420 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
421 HAEMOLYSIS 3 0.0004
422 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
423 RASH PRURITIC 21 0.0004
424 EYE DISCHARGE 4 0.0004
425 GASTROINTESTINAL INFLAMMATION 3 0.0004
426 PRODUCT ODOUR ABNORMAL 4 0.0004
427 PRODUCT USE COMPLAINT 6 0.0004
428 INCONTINENCE 4 0.0004
429 NASAL DISCOMFORT 3 0.0004
430 TRICUSPID VALVE INCOMPETENCE 3 0.0004
431 GINGIVAL PAIN 3 0.0004
432 BREAST PAIN 4 0.0004
433 ANAL FISTULA 2 0.0004
434 NASAL CONGESTION 22 0.0004
435 HAIR TEXTURE ABNORMAL 5 0.0004
436 POOR QUALITY SLEEP 8 0.0004
437 GINGIVITIS 2 0.0004
438 LYMPHADENOPATHY 13 0.0004
439 IMPAIRED GASTRIC EMPTYING 5 0.0004
440 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
441 STAPHYLOCOCCAL INFECTION 12 0.0004
442 INTESTINAL ISCHAEMIA 2 0.0004
443 HYPERKERATOSIS 2 0.0004
444 HUNGER 5 0.0004
445 DEVICE ISSUE 32 0.0004
446 SKIN INFECTION 4 0.0004
447 OCULAR DISCOMFORT 4 0.0004
448 INFUSION SITE ERYTHEMA 3 0.0004
449 ERYTHEMA 73 0.0004
450 BLINDNESS UNILATERAL 5 0.0004
451 BLOOD PRESSURE ABNORMAL 7 0.0004
452 ALOPECIA 69 0.0004
453 SKIN ULCER 9 0.0003
454 EXERCISE TOLERANCE DECREASED 2 0.0003
455 DEVICE DEFECTIVE 6 0.0003
456 DYSPHONIA 20 0.0003
457 LUNG INFILTRATION 3 0.0003
458 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
459 BRADYKINESIA 2 0.0003
460 COVID-19 PNEUMONIA 4 0.0003
461 BLISTER 19 0.0003
462 BRONCHITIS 25 0.0003
463 PRODUCT USE IN UNAPPROVED INDICATION 83 0.0003
464 MYOSITIS 3 0.0003
465 HEARING IMPAIRED 2 0.0003
466 IRRITABILITY 20 0.0003
467 SWELLING 31 0.0003
468 INJECTION SITE VESICLES 2 0.0003
469 CORONARY ARTERY DISEASE 10 0.0003
470 ECONOMIC PROBLEM 5 0.0003
471 ACNE 25 0.0003
472 ADRENAL INSUFFICIENCY 4 0.0003
473 INFLAMMATION 17 0.0003
474 HIDRADENITIS 3 0.0003
475 EXOSTOSIS 3 0.0003
476 BURNING SENSATION 23 0.0003
477 JOINT INJURY 7 0.0003
478 BRAIN NEOPLASM 3 0.0003
479 MIGRAINE 31 0.0003
480 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
481 GENERALISED OEDEMA 4 0.0003
482 PHARYNGITIS 4 0.0003
483 INFUSION SITE EXTRAVASATION 2 0.0003
484 FOREIGN BODY SENSATION IN EYES 2 0.0003
485 ORAL PAIN 7 0.0003
486 CONDITION AGGRAVATED 95 0.0003
487 ATELECTASIS 3 0.0003
488 INFUSION SITE PAIN 4 0.0003
489 DEEP VEIN THROMBOSIS 20 0.0003
490 ANGINA UNSTABLE 2 0.0003
491 BACK DISORDER 5 0.0003
492 NODULE 4 0.0003
493 RENAL TUBULAR NECROSIS 3 0.0003
494 THERAPY CHANGE 3 0.0003
495 HYPOGAMMAGLOBULINAEMIA 2 0.0003
496 HAEMATOCRIT DECREASED 6 0.0003
497 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
498 ILLNESS 31 0.0003
499 FUNGAL INFECTION 10 0.0003
500 DEVICE MALFUNCTION 21 0.0003
501 QUALITY OF LIFE DECREASED 4 0.0003
502 DYSPNOEA EXERTIONAL 11 0.0003
503 ECCHYMOSIS 2 0.0003
504 PERIPHERAL COLDNESS 4 0.0003
505 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
506 DROOLING 2 0.0003
507 LARGE INTESTINE POLYP 2 0.0003
508 PULMONARY HYPERTENSION 6 0.0003
509 LARGE INTESTINE PERFORATION 2 0.0003
510 PETECHIAE 3 0.0003
511 EXTRASYSTOLES 2 0.0003
512 MOUTH ULCERATION 6 0.0003
513 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
514 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
515 PAIN IN JAW 8 0.0003
516 RETCHING 6 0.0003
517 BRONCHOSPASM 4 0.0003
518 HEREDITARY ANGIOEDEMA 3 0.0003
519 GASTROENTERITIS VIRAL 5 0.0003
520 OEDEMA 15 0.0003
521 FAECES SOFT 2 0.0003
522 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
523 SUICIDAL IDEATION 25 0.0003
524 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
525 GASTROINTESTINAL PAIN 3 0.0003
526 TOOTH FRACTURE 3 0.0003
527 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
528 EXPIRED PRODUCT ADMINISTERED 9 0.0003
529 NERVE INJURY 3 0.0003
530 EYE SWELLING 10 0.0003
531 URTICARIA 45 0.0003
532 PULMONARY MASS 4 0.0003
533 IMMUNODEFICIENCY 4 0.0003
534 DEAFNESS 7 0.0003
535 RASH PAPULAR 6 0.0003
536 HYDRONEPHROSIS 2 0.0003
537 REBOUND EFFECT 3 0.0003
538 SUICIDE ATTEMPT 16 0.0003
539 POLLAKIURIA 11 0.0003
540 ROAD TRAFFIC ACCIDENT 11 0.0003
541 INFECTION 38 0.0003
542 VISION BLURRED 36 0.0003
543 INSURANCE ISSUE 4 0.0003
544 NEOPLASM 3 0.0003
545 FREQUENT BOWEL MOVEMENTS 7 0.0003
546 THROAT TIGHTNESS 7 0.0003
547 MADAROSIS 3 0.0003
548 VASCULITIS 3 0.0003
549 BASAL CELL CARCINOMA 4 0.0003
550 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
551 AFFECTIVE DISORDER 2 0.0003
552 ULCER 4 0.0003
553 OBESITY 4 0.0003
554 DEMENTIA 7 0.0003
555 BLOOD DISORDER 2 0.0002
556 NIGHT SWEATS 8 0.0002
557 LIVER DISORDER 11 0.0002
558 FLATULENCE 14 0.0002
559 NO THERAPEUTIC RESPONSE 3 0.0002
560 INTENTIONAL DOSE OMISSION 7 0.0002
561 DECUBITUS ULCER 2 0.0002
562 THROAT IRRITATION 11 0.0002
563 HYPERSOMNIA 7 0.0002
564 ABNORMAL FAECES 2 0.0002
565 SMALL INTESTINAL OBSTRUCTION 3 0.0002
566 IMPAIRED HEALING 8 0.0002
567 SPINAL OPERATION 3 0.0002
568 HYPERAESTHESIA 2 0.0002
569 ESCHERICHIA INFECTION 2 0.0002
570 TENDON RUPTURE 3 0.0002
571 HAIR COLOUR CHANGES 3 0.0002
572 VIRAL INFECTION 8 0.0002
573 NEPHROLITHIASIS 11 0.0002
574 CELLULITIS 12 0.0002
575 SKIN BURNING SENSATION 17 0.0002
576 CHRONIC KIDNEY DISEASE 18 0.0002
577 MUSCLE ATROPHY 3 0.0002
578 INJECTION SITE IRRITATION 3 0.0002
579 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
580 ANOREXIA 3 0.0002
581 INJECTION SITE REACTION 16 0.0002
582 MUSCULOSKELETAL DISCOMFORT 4 0.0002
583 ANURIA 2 0.0002
584 BLOOD MAGNESIUM DECREASED 2 0.0002
585 EXPOSURE VIA SKIN CONTACT 6 0.0002
586 DIPLOPIA 6 0.0002
587 PRODUCT PRESCRIBING ISSUE 5 0.0002
588 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
589 JOINT STIFFNESS 6 0.0002
590 CONTUSION 22 0.0002
591 BEDRIDDEN 3 0.0002
592 NASOPHARYNGITIS 42 0.0002
593 ORAL CANDIDIASIS 3 0.0002
594 COLD SWEAT 4 0.0002
595 DYSMENORRHOEA 3 0.0002
596 SINUSITIS 23 0.0002
597 INFLUENZA 25 0.0002
598 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
599 SNEEZING 5 0.0002
600 URINARY TRACT INFECTION 38 0.0002
601 BLOOD BILIRUBIN INCREASED 6 0.0002
602 SINUS CONGESTION 3 0.0002
603 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
604 INJECTION SITE SWELLING 17 0.0002
605 HEART RATE IRREGULAR 5 0.0002
606 LIMB INJURY 6 0.0002
607 LIP DRY 2 0.0002
608 BALANCE DISORDER 19 0.0002
609 BONE DISORDER 4 0.0002
610 MUSCLE TWITCHING 5 0.0002
611 RHINORRHOEA 14 0.0002
612 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
613 MEDICATION ERROR 12 0.0002
614 ORAL DISCOMFORT 3 0.0002
615 FEELING COLD 6 0.0002
616 APHONIA 3 0.0002
617 HEPATIC STEATOSIS 4 0.0002
618 PRODUCT DOSE OMISSION 14 0.0002
619 APPENDICITIS 2 0.0002
620 DEFORMITY 2 0.0002
621 PAIN IN EXTREMITY 63 0.0002
622 ABDOMINAL PAIN UPPER 44 0.0002
623 BLOOD TEST ABNORMAL 3 0.0002
624 COVID-19 37 0.0002
625 ABDOMINAL DISTENSION 22 0.0002
626 BLOOD URINE PRESENT 4 0.0002
627 PRODUCTIVE COUGH 10 0.0002
628 ARTHRALGIA 87 0.0002
629 PULMONARY FIBROSIS 4 0.0002
630 DRUG PRESCRIBING ERROR 4 0.0002
631 ACUTE RESPIRATORY FAILURE 4 0.0002
632 DIARRHOEA 134 0.0002
633 HYPERCHOLESTEROLAEMIA 2 0.0002
634 DIZZINESS POSTURAL 2 0.0002
635 GASTROENTERITIS 3 0.0002
636 OROPHARYNGEAL PAIN 19 0.0002
637 HYPERSENSITIVITY 38 0.0002
638 KIDNEY INFECTION 4 0.0002
639 COUGH 57 0.0002
640 HOSPICE CARE 2 0.0002
641 EXTRAPYRAMIDAL DISORDER 5 0.0002
642 PERIPHERAL SWELLING 31 0.0002
643 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
644 DRUG INEFFECTIVE 264 0.0002
645 PAIN 123 0.0002
646 SPINAL FRACTURE 4 0.0002
647 BONE LOSS 3 0.0002
648 EXTRA DOSE ADMINISTERED 8 0.0002
649 FEEDING DISORDER 4 0.0002
650 NECK PAIN 11 0.0002
651 EYELID PTOSIS 2 0.0002
652 HEADACHE 123 0.0002
653 THERAPY INTERRUPTED 14 0.0002
654 TINNITUS 9 0.0002
655 HYPOPHAGIA 5 0.0002
656 EUPHORIC MOOD 2 0.0002
657 INITIAL INSOMNIA 2 0.0002
658 ERECTILE DYSFUNCTION 5 0.0002
659 LIMB DISCOMFORT 6 0.0002
660 MUSCULAR WEAKNESS 22 0.0002
661 INJECTION SITE PAIN 59 0.0002
662 BRAIN FOG 3 0.0002
663 FOLLICULITIS 2 0.0002
664 ANHEDONIA 5 0.0002
665 INJECTION SITE DISCOMFORT 2 0.0002
666 BACK PAIN 44 0.0002
667 PNEUMOTHORAX 3 0.0002
668 OSTEOARTHRITIS 8 0.0002
669 SCIATICA 3 0.0002
670 BODY HEIGHT DECREASED 2 0.0002
671 HOT FLUSH 14 0.0002
672 MUSCLE TIGHTNESS 3 0.0002
673 BIPOLAR DISORDER 2 0.0002
674 BACK INJURY 2 0.0002
675 CHOLELITHIASIS 6 0.0002
676 INTENTIONAL PRODUCT MISUSE 16 0.0002
677 INJECTION SITE NODULE 2 0.0002
678 BLOOD PRESSURE DECREASED 12 0.0002
679 OEDEMA PERIPHERAL 22 0.0002
680 FOOT DEFORMITY 2 0.0002
681 DEPRESSION 41 0.0002
682 LIP SWELLING 6 0.0002
683 MENTAL STATUS CHANGES 5 0.0002
684 TRANSAMINASES INCREASED 4 0.0002
685 RASH MACULO-PAPULAR 4 0.0002
686 INJECTION SITE PRURITUS 12 0.0002
687 WEIGHT DECREASED 50 0.0002
688 PANCYTOPENIA 10 0.0002
689 PULMONARY OEDEMA 8 0.0002
690 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
691 TARDIVE DYSKINESIA 5 0.0002
692 CHROMATURIA 4 0.0002
693 FLUSHING 18 0.0002
694 ASTHMA 20 0.0002
695 IMPAIRED DRIVING ABILITY 2 0.0002
696 RED BLOOD CELL COUNT DECREASED 5 0.0002
697 CONSTIPATION 38 0.0002
698 HERPES ZOSTER 10 0.0002
699 LIVER FUNCTION TEST ABNORMAL 5 0.0002
700 UNEVALUABLE EVENT 13 0.0002
701 BLOOD CHOLESTEROL INCREASED 8 0.0002
702 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
703 SURGERY 10 0.0002
704 MYALGIA 29 0.0002
705 HYPOXIA 6 0.0002
706 HEAD DISCOMFORT 3 0.0002
707 SWELLING FACE 11 0.0002
708 BACTERAEMIA 2 0.0002
709 DISEASE RECURRENCE 8 0.0002
710 ACCIDENT 2 0.0002
711 ABDOMINAL DISCOMFORT 28 0.0002
712 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
713 DRUG INTOLERANCE 16 0.0002
714 LOCALISED INFECTION 4 0.0002
715 INSOMNIA 44 0.0002
716 PANIC ATTACK 6 0.0002
717 RESTLESSNESS 6 0.0002
718 INJECTION SITE URTICARIA 4 0.0002
719 RECTAL HAEMORRHAGE 7 0.0002
720 ENCEPHALOPATHY 4 0.0002
721 CARDIOMEGALY 2 0.0002
722 EMOTIONAL DISORDER 5 0.0002
723 ABNORMAL WEIGHT GAIN 2 0.0002
724 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
725 SEPSIS 18 0.0002
726 APPLICATION SITE IRRITATION 2 0.0002
727 MIDDLE INSOMNIA 3 0.0002
728 AGEUSIA 4 0.0002
729 DRY MOUTH 13 0.0002
730 HEPATIC CIRRHOSIS 3 0.0002
731 PRODUCT USE ISSUE 30 0.0002
732 FOOT FRACTURE 3 0.0002
733 DYSPHAGIA 15 0.0002
734 HEAD INJURY 5 0.0002
735 GASTRIC ULCER 3 0.0002
736 FEELING JITTERY 3 0.0002
737 FLUID RETENTION 8 0.0002
738 LETHARGY 9 0.0002
739 DIZZINESS 78 0.0002
740 GASTROINTESTINAL DISORDER 14 0.0002
741 HIP FRACTURE 5 0.0002
742 FATIGUE 121 0.0002
743 ERUCTATION 3 0.0002
744 ANXIETY 44 0.0002
745 RASH GENERALISED 4 0.0002
746 CHOKING 3 0.0002
747 BLOOD CREATININE INCREASED 10 0.0002
748 MUSCULOSKELETAL PAIN 8 0.0002
749 MUSCLE SPASMS 28 0.0002
750 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
751 DISORIENTATION 6 0.0002
752 PNEUMONIA 48 0.0001
753 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
754 PLEURAL EFFUSION 9 0.0001
755 NEUROPATHY PERIPHERAL 14 0.0001
756 DRUG TOXICITY 2 0.0001
757 HYPERTENSION 31 0.0001
758 PRODUCT PREPARATION ERROR 3 0.0001
759 OSTEOPOROSIS 6 0.0001
760 DIVERTICULITIS 4 0.0001
761 HYPOMAGNESAEMIA 2 0.0001
762 WOUND 4 0.0001
763 GAIT DISTURBANCE 27 0.0001
764 DIALYSIS 2 0.0001
765 VOMITING 66 0.0001
766 IMPAIRED WORK ABILITY 3 0.0001
767 HYPOAESTHESIA 21 0.0001
768 ANGINA PECTORIS 4 0.0001
769 WEIGHT INCREASED 31 0.0001
770 FAECES DISCOLOURED 3 0.0001
771 MEMORY IMPAIRMENT 19 0.0001
772 INJECTION SITE BRUISING 11 0.0001
773 CRYING 5 0.0001
774 HYPERGLYCAEMIA 5 0.0001
775 MUSCULOSKELETAL STIFFNESS 12 0.0001
776 CHILLS 16 0.0001
777 ASCITES 4 0.0001
778 INJECTION SITE MASS 5 0.0001
779 URINARY INCONTINENCE 4 0.0001
780 WHEEZING 8 0.0001
781 COLON CANCER 2 0.0001
782 NERVOUSNESS 7 0.0001
783 ADVERSE DRUG REACTION 12 0.0001
784 ATRIAL FIBRILLATION 13 0.0001
785 DECREASED APPETITE 31 0.0001
786 HYPOAESTHESIA ORAL 2 0.0001
787 APHASIA 4 0.0001
788 DYSPEPSIA 13 0.0001
789 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
790 PRODUCT AVAILABILITY ISSUE 3 0.0001
791 ACUTE KIDNEY INJURY 20 0.0001
792 FEELING HOT 8 0.0001
793 PERICARDIAL EFFUSION 3 0.0001
794 ANKLE FRACTURE 2 0.0001
795 ABDOMINAL PAIN 30 0.0001
796 NAUSEA 102 0.0001
797 RENAL DISORDER 6 0.0001
798 DELUSION 2 0.0001
799 LUNG INFECTION 2 0.0001
800 CHEST DISCOMFORT 13 0.0001
801 HAEMATOCHEZIA 7 0.0001
802 ANAPHYLACTIC REACTION 7 0.0001
803 PULMONARY EMBOLISM 12 0.0001
804 PRODUCT PRESCRIBING ERROR 3 0.0001
805 ARTHROPATHY 7 0.0001
806 CYSTITIS 4 0.0001
807 ABSCESS 2 0.0001
808 HYPOTHYROIDISM 4 0.0001
809 METABOLIC ACIDOSIS 4 0.0001
810 BLOOD PRESSURE INCREASED 19 0.0001
811 PYREXIA 43 0.0001
812 FIBROMYALGIA 3 0.0001
813 FALL 41 0.0001
814 BLOOD POTASSIUM INCREASED 2 0.0001
815 DEVICE BREAKAGE 5 0.0001
816 DYSKINESIA 5 0.0001
817 LUNG NEOPLASM MALIGNANT 5 0.0001
818 PRODUCT SUBSTITUTION ISSUE 7 0.0001
819 INFLUENZA LIKE ILLNESS 10 0.0001
820 FEELING ABNORMAL 29 0.0001
821 INJECTION SITE ERYTHEMA 15 0.0001
822 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
823 TREATMENT FAILURE 10 0.0001
824 CYTOMEGALOVIRUS INFECTION 2 0.0001
825 COAGULOPATHY 2 0.0001
826 URINARY RETENTION 4 0.0001
827 ASTHENIA 45 0.0001
828 BONE PAIN 7 0.0001
829 TYPE 2 DIABETES MELLITUS 4 0.0001
830 ABDOMINAL PAIN LOWER 3 0.0001
831 HAEMOGLOBIN DECREASED 12 0.0001
832 DRUG RESISTANCE 3 0.0001
833 GASTRIC DISORDER 4 0.0001
834 JOINT SWELLING 14 0.0001
835 STOMATITIS 7 0.0001
836 RESPIRATORY TRACT INFECTION 3 0.0001
837 SEPTIC SHOCK 5 0.0001
838 MENTAL DISORDER 5 0.0001
839 HAEMORRHAGE 12 0.0001
840 LOCAL SWELLING 2 0.0001
841 APPLICATION SITE ERYTHEMA 3 0.0001
842 EOSINOPHILIA 2 0.0001
843 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
844 MALAISE 50 0.0001
845 GASTRITIS 3 0.0001
846 HEART RATE DECREASED 4 0.0001
847 DEPRESSED MOOD 6 0.0001
848 DRUG ERUPTION 2 0.0001
849 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
850 BREAST CANCER FEMALE 3 0.0001
851 GALLBLADDER DISORDER 2 0.0001
852 DRUG EFFECT DECREASED 6 0.0001
853 DISTURBANCE IN ATTENTION 6 0.0001
854 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
855 HOSPITALISATION 17 0.0001
856 COMPLICATION OF DEVICE REMOVAL 2 0.0001
857 LEUKOCYTOSIS 2 0.0001
858 TREATMENT NONCOMPLIANCE 6 0.0001
859 HYPERHIDROSIS 14 0.0001
860 TREMOR 18 0.0001
861 BLOOD GLUCOSE ABNORMAL 2 0.0001
862 PROCEDURAL PAIN 3 0.0001
863 COGNITIVE DISORDER 5 0.0001
864 EPISTAXIS 8 0.0001
865 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
866 DYSARTHRIA 4 0.0001
867 FEBRILE NEUTROPENIA 7 0.0001
868 COLITIS 4 0.0001
869 NEOPLASM MALIGNANT 7 0.0001
870 MULTIPLE SCLEROSIS 5 0.0001
871 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
872 BLOOD GLUCOSE DECREASED 5 0.0001
873 LOWER LIMB FRACTURE 2 0.0001
874 CHEST PAIN 19 0.0001
875 PALPITATIONS 12 0.0001
876 DISABILITY 2 0.0001
877 RENAL INJURY 3 0.0001
878 RESPIRATORY DISORDER 3 0.0001
879 LEUKOPENIA 5 0.0001
880 BLOOD POTASSIUM DECREASED 3 0.0001
881 CYTOKINE RELEASE SYNDROME 2 0.0001
882 CARDIAC FAILURE CONGESTIVE 8 0.0001
883 INJURY 7 0.0001
884 EMOTIONAL DISTRESS 12 0.0001
885 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
886 VERTIGO 6 0.0001
887 INJURY ASSOCIATED WITH DEVICE 2 0.0001
888 NEUTROPHIL COUNT DECREASED 4 0.0001
889 RENAL FAILURE 13 0.0001
890 DRUG ADMINISTRATION ERROR 3 0.0001
891 DEHYDRATION 13 0.0001
892 FEMUR FRACTURE 3 0.0001
893 SWOLLEN TONGUE 3 0.0001
894 SPEECH DISORDER 5 0.0001
895 PARAESTHESIA 15 0.0001
896 EATING DISORDER 2 0.0001
897 MOVEMENT DISORDER 3 0.0001
898 IRRITABLE BOWEL SYNDROME 2 0.0001
899 CONFUSIONAL STATE 15 0.0001
900 INCORRECT DOSE ADMINISTERED 21 0.0001
901 DYSPNOEA 52 0.0001
902 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
903 HEART RATE INCREASED 9 0.0001
904 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
905 SYNCOPE 9 0.0001
906 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
907 HYPOTENSION 18 0.0001
908 SOMNOLENCE 18 0.0001
909 ARTHRITIS 7 0.0001
910 OXYGEN SATURATION DECREASED 5 0.0001
911 HYPONATRAEMIA 5 0.0001
912 NEUTROPENIA 12 0.0001
913 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
914 HAEMATURIA 3 0.0001
915 CARDIAC FAILURE 7 0.0001
916 NIGHTMARE 3 0.0001
917 HYPOKALAEMIA 4 0.0001
918 HYPERKALAEMIA 3 0.0001
919 BLOOD GLUCOSE INCREASED 16 0.0001
920 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
921 PLATELET COUNT DECREASED 9 0.0001
922 CEREBRAL HAEMORRHAGE 3 0.0001
923 MOBILITY DECREASED 6 0.0001
924 BLOOD PRESSURE FLUCTUATION 2 0.0001
925 DIABETIC KETOACIDOSIS 2 0.0001
926 DRUG EFFECT INCOMPLETE 3 0.0001
927 HYPOGLYCAEMIA 4 0.0001
928 C-REACTIVE PROTEIN INCREASED 3 0.0001
929 ILL-DEFINED DISORDER 5 0.0001
930 LUNG DISORDER 4 0.0001
931 DYSURIA 3 0.0001
932 AGGRESSION 4 0.0001
933 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
934 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
935 DIABETES MELLITUS 6 0.0001
936 ANAEMIA 15 0.0001
937 DRUG DOSE OMISSION 13 0.0001
938 LOSS OF CONSCIOUSNESS 10 0.0001
939 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
940 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
941 DISEASE PROGRESSION 9 0.0001
942 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
943 INJECTION SITE HAEMORRHAGE 6 0.0001
944 JAUNDICE 2 0.0001
945 THROMBOCYTOPENIA 8 0.0001
946 WITHDRAWAL SYNDROME 3 0.0001
947 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
948 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
949 CONVULSION 4 0.0001
950 HYPOACUSIS 3 0.0001
951 PRODUCT STORAGE ERROR 6 0.0001
952 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
953 AGITATION 5 0.0001
954 ANGIOEDEMA 3 0.0001
955 LABORATORY TEST ABNORMAL 2 0.0001
956 TACHYCARDIA 6 0.0001
957 HEPATIC FAILURE 2 0.0001
958 INJECTION SITE RASH 2 0.0001
959 EXPOSURE DURING PREGNANCY 4 0.0001
960 CARDIAC DISORDER 6 0.0001
961 DRUG-INDUCED LIVER INJURY 2 0.0001
962 ARRHYTHMIA 3 0.0001
963 THROMBOSIS 5 0.0001
964 LACTIC ACIDOSIS 2 0.0001
965 AMNESIA 4 0.0001
966 INFUSION RELATED REACTION 4 0.0001
967 GAIT INABILITY 2 0.0001
968 ANGER 2 0.0001
969 HEPATIC ENZYME INCREASED 4 0.0001
970 PANCREATITIS 3 0.0001
971 ACCIDENTAL OVERDOSE 2 0.0001
972 BREAST CANCER 5 0.0001
973 HEPATIC FUNCTION ABNORMAL 2 0.0001
974 HALLUCINATION 4 0.0001
975 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
976 CARDIO-RESPIRATORY ARREST 2 0.0000
977 RENAL IMPAIRMENT 4 0.0000
978 MYOCARDIAL INFARCTION 8 0.0000
979 DRUG WITHDRAWAL SYNDROME 4 0.0000
980 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
981 SEIZURE 5 0.0000
982 INTERSTITIAL LUNG DISEASE 2 0.0000
983 UNDERDOSE 3 0.0000
984 DYSGEUSIA 3 0.0000
985 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
986 BRADYCARDIA 2 0.0000
987 CEREBROVASCULAR ACCIDENT 6 0.0000
988 ADVERSE EVENT 3 0.0000
989 DEATH 22 0.0000
990 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
991 CARDIAC ARREST 2 0.0000
992 DRUG ABUSE 2 0.0000
993 DRUG INTERACTION 3 0.0000